Causal Inference in Oncology: Why, What, How and When
Publication date
2025-02
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Oncologists are faced with choosing the best treatment for each patient, based on the available evidence from randomized controlled trials (RCTs) and observational studies. RCTs provide estimates of the average effects of treatments on groups of patients, but they may not apply in many real-world scenarios where for example patients have different characteristics than the RCT participants, or where different treatment variants are considered. Causal inference defines what a treatment effect is and how it may be estimated with RCTs or outside of RCTs with observational – or ‘real-world’ – data. In this review, we introduce the field of causal inference, explain what a treatment effect is and what important challenges are with treatment effect estimation with observational data. We then provide a framework for conducting causal inference studies and describe when in oncology causal inference from observational data may be particularly valuable. Recognizing the strengths and limitations of both RCTs and observational causal inference provides a way for more informed and individualized treatment decision-making in oncology.
Keywords
Causal inference, confounding, individualised cancer care, realworld data, research methodology, treatment effect heterogeneity, Oncology, Radiology Nuclear Medicine and imaging
Citation
van Amsterdam, W A C, Elias, S & Ranganath, R 2025, 'Causal Inference in Oncology : Why, What, How and When', Clinical Oncology, vol. 38, 103616. https://doi.org/10.1016/j.clon.2024.07.002